In addition to its anti-apoptotic function, BCL2 has a suggested role in neuro-endocrine differentiation in colon carcinomas [31] and its downregulation is associated with poor prognosis in breast cancer [32]. This evidence concerns the gene BCL2 and breast carcinoma.